How big is the Artificial Intelligence in Medicine Market?

The Artificial Intelligence in Medicine Market size is expected to reach USD 11.66 billion in 2024 and grow at a CAGR of 25.83% to reach USD 36.79 billion by 2029. Read More

What is the current Artificial Intelligence in Medicine Market size?

In 2024, the Artificial Intelligence in Medicine Market size is expected to reach USD 11.66 billion. Read More

Who are the key players in Artificial Intelligence in Medicine Market?

Atomwise Inc., Novo Nordisk A/S, Modernizing Medicine Inc., Nano-X Imaging Ltd and Medasense Biometrics Limited are the major companies operating in the Artificial Intelligence in Medicine Market. Read More

Which is the fastest growing region in Artificial Intelligence in Medicine Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Artificial Intelligence in Medicine Market?

In 2024, the North America accounts for the largest market share in Artificial Intelligence in Medicine Market. Read More

What years does this Artificial Intelligence in Medicine Market cover, and what was the market size in 2023?

In 2023, the Artificial Intelligence in Medicine Market size was estimated at USD 9.27 billion. The report covers the Artificial Intelligence in Medicine Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Artificial Intelligence in Medicine Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Artificial Intelligence in Medicine Market

Artificial Intelligence in Medicine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

the Artificial Intelligence (AI) in Healthcare Market is Segmented by Application Type (Medical Administration and Support, Patient Management, Research and Development), Type (Hardware, Software, Services), and Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa). the Market Sizes and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

Artificial Intelligence in Medicine Industry Overview

The overall competitive rivalry remains moderately high in the Market studied. The growing existence of big players in the industry is anticipated to intensify competitive rivalry during the projection period. Incumbents, such as IBM Watson Health, Atomwise Inc., etc., considerably influence the overall Market.

June 2023- Stanford Medicine and Stanford Institute for Human-Centered Artificial Intelligence (HAI) launched Responsible AI for Safe and Equitable Health (RAISE-Health), intending to address critical ethical and safety issues regarding the technology. RAISE-Health will be co-led by Stanford School of Medicine Dean Lloyd Minor, M.D., and Stanford HAI co-director and computer science professor Fei-Fei Li, Ph.D. The two will establish a go-to platform for responsible AI in health and medicine, define a structured framework for ethical standards and safeguards, and regularly conduct expert discussions on the subject.
September 2022 - AiCure announced its clinical site services program opening. The new program offers sites end-to-end, personalized support and monitoring of KPIs relating to adherence, compliance, data management, and use of technology among study participants. With this solution, AiCure provides research coordinators with proactive insights into their patient demographics to reduce risk across studies and improve workflows.